CLINICAL_TRIALS
trial_result
· 2016-07-11
Clinical Trial Update: Trial of LBH589 in Metastatic Thyroid Cancer [Phase 2]
Summary
Phase 2 trial update for LBH589 (panobinostat) in metastatic thyroid carcinoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Thyroid Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-07-11